Abstract
The introduction of the Papanicolaou (Pap) test as a routine screening test has resulted in a 70% reduction in the incidence of cervical cancer in the United States over the past five decades. In 2003 over 50 million women underwent cervical cancer screening, revealing close to 2.5 million abnormalities. Screening is offered by a variety of health care providers in various specialties.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Reading
ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383–92.
ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393–1400.
ALTS Study et al. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397–402.
Cox JT, Schiffman M, Solomon D, for the ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406–12.
Fetters MD, Lieberman RW, Abrahamse PH, Sanghvi RV, Sonnad SS. Cost-effectiveness of Pap smear screening for vaginal cancer after total hysterectomy for benign disease. J Lower Genital Tract Dis 2003;7(3):194–202.
Mao C. Do liquid-based Pap smears need a transformation zone component? Cont Ob/Gyn 2003;48(7):78–83.
McCance DJ. Human Papilloma Viruses: Perspectives in Medical Virology, Vol. 8. Amsterdam: Elsevier Science B.V.; 2002.
Monk BJ, Brewster WR. Does the ALTS trial apply to the community-based practitioner? Am J Obstet Gynecol 2003;188:1381–2.
Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342–62.
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr., Young N. The 2001 Bethesda System, terminology for reporting results of cervical cytology. JAMA 2002;287:2114–19.
Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 concensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120–9.
Wright TC, Schiffman M, Solomon D, Cox TJ, Garcia F, Goldie S, Hatch K, Noller K, Roach N, Runowicz C, Saslow D. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology screening. Obstet Gynecol 2004;103:304–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Guido, R.S. (2007). Abnormal Pap Smear: Gynecologic Pathology and Management. In: Primary Care in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-32328-2_7
Download citation
DOI: https://doi.org/10.1007/978-0-387-32328-2_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-32327-5
Online ISBN: 978-0-387-32328-2
eBook Packages: MedicineMedicine (R0)